Electrocardiogram Monitoring Market Size, Share & Trend Analysis - Global - 2025-2031 - Includes: ECG Monitor Market and ECG Electrode Market
Description
Global Electrocardiogram Monitoring Market Report, 2025 Edition
Executive Summary
The global electrocardiogram (ECG) monitoring market was valued at 1.7 billion dollars in 2024. The market is projected to grow at a 1.7 percent CAGR to reach 1.9 billion dollars by 2031. As cardiovascular disease remains a leading cause of mortality worldwide, ECG monitoring is essential for diagnosis, early detection and ongoing management of cardiac rhythm disorders.
This report covers the full global market for ECG monitors and ECG electrodes. It quantifies unit sales, average selling prices, market values, growth trends and competitive shares. It also examines procedure volumes, clinical demand drivers, market limiters and competitive dynamics across all major regions.
New technologies are emerging in cardiac rhythm diagnostics, including enhanced integration with artificial intelligence and greater connectivity with smart devices. These innovations support more efficient diagnostics and allow clinicians across departments to access patient data in real time.
Historical data is included from 2021 to 2024, and forecasts extend to 2031. This report provides a comprehensive framework for understanding how ECG monitoring is evolving in hospitals, clinics, outpatient centers and remote monitoring programs worldwide.
Market Overview
Electrocardiogram monitoring is one of the most widely used diagnostic procedures for evaluating cardiac function. It plays a crucial role in emergency departments, intensive care units, cardiology clinics, primary care offices and home monitoring programs. ECG monitoring helps detect arrhythmias, conduction abnormalities, ischemic changes and other indicators that guide treatment.
The global ECG monitoring market includes devices for resting ECG, stress testing and long term Holter monitoring. It also includes the broad electrode market, which supports both routine and advanced cardiac diagnostics. Electrodes represent a recurring revenue source because they must be replaced regularly, which sustains strong annual unit volumes regardless of economic conditions.
Clinical guidelines worldwide emphasize early detection and prevention. Cardiac patients without a prior diagnosis often ignore early symptoms. ECG tests help identify risk earlier, reduce the likelihood of sudden cardiac events and improve the management of chronic conditions such as heart failure.
In developing regions, access to ECG monitoring is improving as healthcare infrastructure grows. However, in many countries, care pathways remain time consuming, especially when patients must travel long distances. Technologies that allow rapid diagnosis, remote review and data sharing support better outcomes in regions where follow up visits are difficult.
The market is influenced by advancements in AI-enabled ECG interpretation. Early-stage research, including studies conducted by Mayo Clinic in 2019, demonstrated the potential of AI to determine patient characteristics such as gender and age group from ECG data. While these findings require further validation, the results highlight the potential for advanced diagnostics to become more integrated with ECG systems.
In parallel, smartphone integration and digital data management are reshaping how ECG results are recorded, shared and analyzed. These trends are expected to strengthen over the forecast period as clinicians and hospitals adopt connected platforms.
Market Drivers
Increasing Focus on Early Diagnosis and Disease Prevention
Early diagnosis is essential for preventing sudden cardiac death and managing conditions such as heart failure, arrhythmia and ischemic heart disease. Electrocardiogram testing provides a reliable and accessible method for identifying cardiovascular abnormalities.
Studies show that many cardiac patients do not seek care when symptoms emerge, which increases risk. Routine ECG testing assists in risk management, reduces events and supports earlier treatment. Countries across all regions are increasing their attention to preventive care, and ECG monitoring is a central tool in that strategy.
In some developing countries, barriers limit access to timely care. Patients often spend significant time traveling to clinics or hospitals for evaluation. Because follow up visits are difficult, diagnostic tools that provide fast and reliable results during a single visit are highly valued. ECG testing provides immediate results and fits these needs, which helps drive adoption in both urban and rural environments.
Development of New Technologies
Innovation is accelerating within the cardiac rhythm management space. Research teams are experimenting with AI to enhance ECG interpretation. The Mayo Clinic’s 2019 study used ECG signals from 500,000 patients and trained an algorithm that identified gender with 90 percent accuracy and age group with 72 percent accuracy. Although further research is required before widespread clinical use, it demonstrates how AI may improve efficiency and support diagnostic decision-making.
Compatibility with smart devices is also expanding. ECG systems that integrate with smartphones or tablets allow clinicians to access data from different departments. This improves collaboration across emergency departments, cardiology clinics and primary care settings.
Convenience and Growth of Holter Monitoring
Holter monitoring has traditionally been considered inconvenient for patients due to the requirement of returning to testing centers to download results or transmit data manually. Modern systems resolve this issue by transmitting recordings wirelessly to smart devices or cloud platforms.
Mobile cardiovascular telemetry devices allow physicians to query data directly. They no longer need to wait for the patient or device to upload information. Holter devices are also becoming more compact and comfortable. Wearable monitors enable patients to go about their daily activities with minimal disruption.
QardioCore, introduced in 2017, is an example of a wearable ECG monitor designed for long term data collection through smartphone-connected platforms. This type of innovation is accelerating across the market. As monitors become smaller, more discreet and easier to use, demand increases across outpatient and home monitoring programs.
Market Limiters
Mature Market Conditions
The ECG monitoring market is mature, especially in the resting ECG and stress testing segments. Replacement sales dominate purchasing behavior. Most facilities already own the necessary equipment, and new purchases are driven by replacement cycles rather than the addition of new systems.
Because these markets are saturated, overall growth in these segments remains limited. Facilities generally replace their systems only when existing equipment becomes outdated, incompatible with new connectivity requirements or unable to meet regulatory standards.
Cost Barrier for Patients
The cost of ECG procedures varies widely depending on location, insurance coverage and reimbursement. ECG exams typically include procedural costs and analysis fees. Although rural clinics may offer discounted services, overall costs can be high for patients, reducing usage in certain populations.
Cost is particularly prohibitive in regions where insurance coverage is limited. Patients may avoid diagnostics, which affects the total procedure volumes that drive ECG monitor usage.
Consolidation of Hospitals and Pressure on Profit Margins
The healthcare industry is undergoing consolidation across many developed economies. Private practices continue to merge into larger hospital systems. This consolidation increases the leverage of group purchasing organizations. GPOs negotiate lower prices, which applies downward pressure on average selling prices for ECG monitors and electrodes.
Hospitals also face reduced profit margins, which influence purchasing decisions. Even as alternate care settings grow, they cannot fully offset reductions in purchasing caused by consolidation. These conditions limit the total addressable market and encourage suppliers to compete more aggressively on price.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Market forecasts
Market growth rates
Units sold
Average selling prices
Qualitative Coverage
Growth trends
Market limiters
Competitive analysis and SWOT
Company profiles and product portfolios
Mergers and acquisitions
FDA recalls and regulatory updates
Disruptive technologies
Disease overviews and procedure trends
Time Frame
Historical data from 2021 to 2024
Base year 2024
Forecasts to 2031
Data Sources
Interviews with industry leaders
Government physician and hospital data
Regulatory data
Hospital private data
Import and export statistics
iData Research internal database
Markets Covered and Segmentation
ECG Monitor Market
Further Segmented Into:
Resting ECG
Stress testing
Holter monitoring
ECG Electrode Market
Includes disposable, limited reuse and specialty electrodes used across all care settings.
Competitive Analysis
GE Healthcare
GE Healthcare was the leading competitor in the global ECG monitoring market in 2024. The company held the largest share in the ECG monitor segment due to its strong offerings in resting ECG, stress testing and Holter monitoring. GE’s strength is further supported by its portfolio of PACS and HIS technologies, which enable seamless integration of ECG data into broader hospital systems.
Cardinal Health
Cardinal Health was the second-leading competitor, with strong positions in the ECG electrode market. Its market share grew after acquiring Medtronic’s patient recovery business in 2017 for 6.1 billion dollars, which included the Covidien electrode product lines. This acquisition provided Cardinal with a comprehensive electrode portfolio, supporting its leadership in consumables that drive recurring revenue.
Philips Healthcare
Philips Healthcare maintained a strong presence in the ECG monitor market with a particular focus on Holter monitors. Its Holter scanners are known for efficient workflows and advanced features. Philips also has a strong presence in PACS and HIS systems, which positions the company well for managing ECG data across clinical settings.
Together, these companies shape global expectations around system integration, accuracy and workflow efficiency. Other competitors include firms specializing in digital wearable monitors, electrodes and value-oriented products.
Technology and Practice Trends
Advances in ECG monitoring continue to improve clinical efficiency, patient experience and data accessibility. Major trends include:
Growth in AI-enabled ECG interpretation, which may expand diagnostic capabilities
Increased smartphone integration for data transmission, storage and sharing
Development of compact and wearable ECG monitors that increase patient comfort
Expansion of mobile cardiovascular telemetry for real time monitoring
Improved data management systems that link ECG results to PACS and HIS platforms
Clinical preference for more efficient workflows that reduce time spent retrieving or uploading data
These trends support adoption in both hospital environments and remote monitoring programs.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where will growth occur within ECG monitoring, and which segments will show the strongest demand
How are emerging technologies, including AI and smartphone integration, shaping the evolution of ECG systems
What is the impact of consumable electrode usage on recurring revenue
How do cost barriers and varying reimbursement policies affect adoption across regions
Which competitors lead the global and regional markets, and what strategies contribute to their positions
How does consolidation influence hospital purchasing behavior
What factors should commercial teams consider when planning future product portfolios
This report provides a complete framework for quantifying market demand, assessing competition and planning strategy for the ECG monitoring market through 2031.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Executive Summary
The global electrocardiogram (ECG) monitoring market was valued at 1.7 billion dollars in 2024. The market is projected to grow at a 1.7 percent CAGR to reach 1.9 billion dollars by 2031. As cardiovascular disease remains a leading cause of mortality worldwide, ECG monitoring is essential for diagnosis, early detection and ongoing management of cardiac rhythm disorders.
This report covers the full global market for ECG monitors and ECG electrodes. It quantifies unit sales, average selling prices, market values, growth trends and competitive shares. It also examines procedure volumes, clinical demand drivers, market limiters and competitive dynamics across all major regions.
New technologies are emerging in cardiac rhythm diagnostics, including enhanced integration with artificial intelligence and greater connectivity with smart devices. These innovations support more efficient diagnostics and allow clinicians across departments to access patient data in real time.
Historical data is included from 2021 to 2024, and forecasts extend to 2031. This report provides a comprehensive framework for understanding how ECG monitoring is evolving in hospitals, clinics, outpatient centers and remote monitoring programs worldwide.
Market Overview
Electrocardiogram monitoring is one of the most widely used diagnostic procedures for evaluating cardiac function. It plays a crucial role in emergency departments, intensive care units, cardiology clinics, primary care offices and home monitoring programs. ECG monitoring helps detect arrhythmias, conduction abnormalities, ischemic changes and other indicators that guide treatment.
The global ECG monitoring market includes devices for resting ECG, stress testing and long term Holter monitoring. It also includes the broad electrode market, which supports both routine and advanced cardiac diagnostics. Electrodes represent a recurring revenue source because they must be replaced regularly, which sustains strong annual unit volumes regardless of economic conditions.
Clinical guidelines worldwide emphasize early detection and prevention. Cardiac patients without a prior diagnosis often ignore early symptoms. ECG tests help identify risk earlier, reduce the likelihood of sudden cardiac events and improve the management of chronic conditions such as heart failure.
In developing regions, access to ECG monitoring is improving as healthcare infrastructure grows. However, in many countries, care pathways remain time consuming, especially when patients must travel long distances. Technologies that allow rapid diagnosis, remote review and data sharing support better outcomes in regions where follow up visits are difficult.
The market is influenced by advancements in AI-enabled ECG interpretation. Early-stage research, including studies conducted by Mayo Clinic in 2019, demonstrated the potential of AI to determine patient characteristics such as gender and age group from ECG data. While these findings require further validation, the results highlight the potential for advanced diagnostics to become more integrated with ECG systems.
In parallel, smartphone integration and digital data management are reshaping how ECG results are recorded, shared and analyzed. These trends are expected to strengthen over the forecast period as clinicians and hospitals adopt connected platforms.
Market Drivers
Increasing Focus on Early Diagnosis and Disease Prevention
Early diagnosis is essential for preventing sudden cardiac death and managing conditions such as heart failure, arrhythmia and ischemic heart disease. Electrocardiogram testing provides a reliable and accessible method for identifying cardiovascular abnormalities.
Studies show that many cardiac patients do not seek care when symptoms emerge, which increases risk. Routine ECG testing assists in risk management, reduces events and supports earlier treatment. Countries across all regions are increasing their attention to preventive care, and ECG monitoring is a central tool in that strategy.
In some developing countries, barriers limit access to timely care. Patients often spend significant time traveling to clinics or hospitals for evaluation. Because follow up visits are difficult, diagnostic tools that provide fast and reliable results during a single visit are highly valued. ECG testing provides immediate results and fits these needs, which helps drive adoption in both urban and rural environments.
Development of New Technologies
Innovation is accelerating within the cardiac rhythm management space. Research teams are experimenting with AI to enhance ECG interpretation. The Mayo Clinic’s 2019 study used ECG signals from 500,000 patients and trained an algorithm that identified gender with 90 percent accuracy and age group with 72 percent accuracy. Although further research is required before widespread clinical use, it demonstrates how AI may improve efficiency and support diagnostic decision-making.
Compatibility with smart devices is also expanding. ECG systems that integrate with smartphones or tablets allow clinicians to access data from different departments. This improves collaboration across emergency departments, cardiology clinics and primary care settings.
Convenience and Growth of Holter Monitoring
Holter monitoring has traditionally been considered inconvenient for patients due to the requirement of returning to testing centers to download results or transmit data manually. Modern systems resolve this issue by transmitting recordings wirelessly to smart devices or cloud platforms.
Mobile cardiovascular telemetry devices allow physicians to query data directly. They no longer need to wait for the patient or device to upload information. Holter devices are also becoming more compact and comfortable. Wearable monitors enable patients to go about their daily activities with minimal disruption.
QardioCore, introduced in 2017, is an example of a wearable ECG monitor designed for long term data collection through smartphone-connected platforms. This type of innovation is accelerating across the market. As monitors become smaller, more discreet and easier to use, demand increases across outpatient and home monitoring programs.
Market Limiters
Mature Market Conditions
The ECG monitoring market is mature, especially in the resting ECG and stress testing segments. Replacement sales dominate purchasing behavior. Most facilities already own the necessary equipment, and new purchases are driven by replacement cycles rather than the addition of new systems.
Because these markets are saturated, overall growth in these segments remains limited. Facilities generally replace their systems only when existing equipment becomes outdated, incompatible with new connectivity requirements or unable to meet regulatory standards.
Cost Barrier for Patients
The cost of ECG procedures varies widely depending on location, insurance coverage and reimbursement. ECG exams typically include procedural costs and analysis fees. Although rural clinics may offer discounted services, overall costs can be high for patients, reducing usage in certain populations.
Cost is particularly prohibitive in regions where insurance coverage is limited. Patients may avoid diagnostics, which affects the total procedure volumes that drive ECG monitor usage.
Consolidation of Hospitals and Pressure on Profit Margins
The healthcare industry is undergoing consolidation across many developed economies. Private practices continue to merge into larger hospital systems. This consolidation increases the leverage of group purchasing organizations. GPOs negotiate lower prices, which applies downward pressure on average selling prices for ECG monitors and electrodes.
Hospitals also face reduced profit margins, which influence purchasing decisions. Even as alternate care settings grow, they cannot fully offset reductions in purchasing caused by consolidation. These conditions limit the total addressable market and encourage suppliers to compete more aggressively on price.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Market forecasts
Market growth rates
Units sold
Average selling prices
Qualitative Coverage
Growth trends
Market limiters
Competitive analysis and SWOT
Company profiles and product portfolios
Mergers and acquisitions
FDA recalls and regulatory updates
Disruptive technologies
Disease overviews and procedure trends
Time Frame
Historical data from 2021 to 2024
Base year 2024
Forecasts to 2031
Data Sources
Interviews with industry leaders
Government physician and hospital data
Regulatory data
Hospital private data
Import and export statistics
iData Research internal database
Markets Covered and Segmentation
ECG Monitor Market
Further Segmented Into:
Resting ECG
Stress testing
Holter monitoring
ECG Electrode Market
Includes disposable, limited reuse and specialty electrodes used across all care settings.
Competitive Analysis
GE Healthcare
GE Healthcare was the leading competitor in the global ECG monitoring market in 2024. The company held the largest share in the ECG monitor segment due to its strong offerings in resting ECG, stress testing and Holter monitoring. GE’s strength is further supported by its portfolio of PACS and HIS technologies, which enable seamless integration of ECG data into broader hospital systems.
Cardinal Health
Cardinal Health was the second-leading competitor, with strong positions in the ECG electrode market. Its market share grew after acquiring Medtronic’s patient recovery business in 2017 for 6.1 billion dollars, which included the Covidien electrode product lines. This acquisition provided Cardinal with a comprehensive electrode portfolio, supporting its leadership in consumables that drive recurring revenue.
Philips Healthcare
Philips Healthcare maintained a strong presence in the ECG monitor market with a particular focus on Holter monitors. Its Holter scanners are known for efficient workflows and advanced features. Philips also has a strong presence in PACS and HIS systems, which positions the company well for managing ECG data across clinical settings.
Together, these companies shape global expectations around system integration, accuracy and workflow efficiency. Other competitors include firms specializing in digital wearable monitors, electrodes and value-oriented products.
Technology and Practice Trends
Advances in ECG monitoring continue to improve clinical efficiency, patient experience and data accessibility. Major trends include:
Growth in AI-enabled ECG interpretation, which may expand diagnostic capabilities
Increased smartphone integration for data transmission, storage and sharing
Development of compact and wearable ECG monitors that increase patient comfort
Expansion of mobile cardiovascular telemetry for real time monitoring
Improved data management systems that link ECG results to PACS and HIS platforms
Clinical preference for more efficient workflows that reduce time spent retrieving or uploading data
These trends support adoption in both hospital environments and remote monitoring programs.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where will growth occur within ECG monitoring, and which segments will show the strongest demand
How are emerging technologies, including AI and smartphone integration, shaping the evolution of ECG systems
What is the impact of consumable electrode usage on recurring revenue
How do cost barriers and varying reimbursement policies affect adoption across regions
Which competitors lead the global and regional markets, and what strategies contribute to their positions
How does consolidation influence hospital purchasing behavior
What factors should commercial teams consider when planning future product portfolios
This report provides a complete framework for quantifying market demand, assessing competition and planning strategy for the ECG monitoring market through 2031.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Table of Contents
66 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
